• Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Our Partners
  • Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Dry Eye Severity Directly Linked with Decreased Reading Rates

October 29, 2020/0 Comments/in Blog Posts/by michele

This post is part of BostonSight’s archival content and was originally authored by Janice M. Epstein in April 2015. Some content has been updated to be current. 

Reading is a critical life skill, essential for communicating with others, keeping up with the news, understanding instructions, succeeding at work, using a computer, or simply for enjoyment. Vision problems can seriously impede reading and make these necessary tasks extremely difficult and, in some cases, impossible.

BostonSight PROSETM patients with moderate to severe dry eye disease know firsthand the impact of their symptoms on their ability to read the printed word. In fact, a 2010 survey conducted by BostonSight found that 81% of survey respondents with severe dry eye reported difficulty reading regular print newspapers, magazines, or websites.

Dry eye contributes to problems with visual acuity but until recently most data with regard to the impact on reading has been self-reported by patients. In addition, the pain and photophobia (light-sensitivity) that result from dry eye also make reading a challenge.  A study confirms what those who suffer from moderate to severe dry eye already experience:  a direct correlation between reading speed and dry eye. These findings, published in the January 2013 issue of Optometry and Vision Science, showed that people with diagnosed dry eye disease read at slower rates than those without dry eye. In addition, reading speed decreased in direct relationship to the degree of dry eye disease severity.

These study findings suggest that evaluations of reading speed may serve as indicators of dry eye severity and could be used to monitor the degree to which medical treatments are benefiting each patient. In addition, when struggling with a chronic health condition such as dry eye, it’s important to have your symptoms and challenges validated by scientific research. Research that confirms patient-reported symptoms can lead to better management and treatment strategies for these conditions.

If you still struggle to read even with vision-correcting lenses and treatment for your eye health condition, you might look to technology for help. Digital tablets and e-readers may improve reading ability in those with low vision. Other assistive devices for low vision, such as magnifiers or screen readers, can also make reading easier.

Have you experienced more difficulty reading with increased dry eye symptoms? What strategies have most helped you to cope?

https://www.bostonsight.org/wp-content/uploads/2026/06/112653079_s.jpg 565 847 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2020-10-29 18:56:412020-10-29 18:56:41Dry Eye Severity Directly Linked with Decreased Reading Rates

BostonSight Increases Accessibility of Higher Order Abberation (HOA) Correction in Vision Care

October 20, 2020/0 Comments/in Press Release/by michele

Pushes Industry Forward Through SmartSight™ HOA Collaborator Program and Open-Aberrometer Platform

October 20, 2020, Needham, MA – BostonSight®, a nonprofit eye healthcare organization and research center dedicated to saving sight and improving quality of life, announced today their HOA Collaborator Program, partnering with eyecare professionals to offer SmartSight™ higher order aberration (HOA) correction technology in specialty lenses.

BostonSight has been actively treating patients with HOA technology for more than 20 years, starting with front surface eccentricity features in their lenses and moving forward to full wavefront correction. The organization is expanding access to this innovative technology to help additional patients who could benefit.

HOAs are imperfections in the ocular visual system that result in visually significant distortions, such as glare, halos, blurring, starburst patterns, double vision or difficulty seeing at night. Typical contact lenses or glasses are ineffective at correcting these aberrations, however BostonSight PROSE™ devices and BostonSight SCLERAL lenses with the addition of SmartSight HOA correcting technology have shown promising results.

BostonSight’s HOA correcting technology uses an open-aberrometer platform along with a simple step-by-step guide and consultation to help novice to experienced practitioners harness the benefits of HOA correction and improve patient vision.

“We are excited to collaborate with our BostonSight PROSE and BostonSight SCLERAL networks to further enhance the HOA technology that BostonSight has offered for years,” said Dr. Daniel Brocks, BostonSight’s Chief Medical Officer. “Our partners and colleagues are experts in patient care and have vast knowledge about patients’ vision challenges. Through collaboration and our open-aberrometer platform, together we can increase understanding and accessibility to HOA correction, helping more people see clearly.”

“BostonSight advances specialty lens technology through our academic medical center model, leveraging 30 years of scleral lens design and training, an on-site patient clinic, and an active research center,” said Sara Yost, BostonSight President and CEO. “This model allows BostonSight to continually learn from patient and practitioner feedback, identify needs, and develop technologies and treatments that lead to better patient care and outcomes. By joining the HOA Collaborator Program, practitioners can help push the industry forward.”

BostonSight PROSE and SCLERAL network partners, or other Optometrists or Ophthalmologists who have access to an aberrometer and are interested in joining the HOA Collaborator Program may inquire at https://www.bostonsight.org/our-research/.  At this time, there is no additional charge to practitioners to utilize SmartSight HOA technology with any BostonSight lens order.

To join the BostonSight SCLERAL Partner Network, join at no cost at www.bostonsightscleral.org/get-started.

About BostonSight®
BostonSight has saved the sight of thousands of individuals suffering from ocular surface disease, corneal disease, injury, or damage with BostonSight PROSE™ treatment. Founded in 1992, the Needham, MA Center of Excellence includes a clinic, research center, state-of-the-art FDA-certified and ISO-compliant manufacturing lab, and patient and family support center.  BostonSight SCLERAL was launched in 2017 to expand access to global scleral lens technology. Eye care practitioners achieve a fast, effective scleral lens fit that provides optimal vision and comfort for patients while attaining long-term eye health.  SCLERALIG is the newest innovation in BostonSight’s portfolio, using image topography to map the eye for a truly custom scleral lens fit. BostonSight envisions a world where no one suffers loss of sight from corneal irregularities or ocular surface disease. Learn more at www.bostonsight.org.

Contact:
Michele Hart
BostonSight
(617) 669-4225
mhart@bostonsight.org

###

https://www.bostonsight.org/wp-content/uploads/2026/06/SmartSight-HOA-BostonSight.png 500 1000 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2020-10-20 11:00:052020-10-20 11:00:05BostonSight Increases Accessibility of Higher Order Abberation (HOA) Correction in Vision Care

Pages

  • About
  • Clinical Trials and R&D Services
  • Conditions We Treat
  • Contact Us
  • Dry Eye
  • Education
  • Find a PROSE Clinic
  • FitAcademy
  • FitAcademy for Residents
  • FitAcademy Immersive
  • FitAcademy International
  • GVHD
  • Home
  • Keratoconus
  • Manufacturing
  • Needham PROSE Clinic
  • News
  • Notice of Privacy Practices for Patients
  • Ophthalmology Resident Lectures
  • Our Approach
  • Our Partners
  • Our People
  • Our Products
  • Patient Care
  • Patient Information Booklet
  • Patient Resources
  • Patient Stories
  • Pediatrics
  • Post-Corneal Transplant
  • Post-LASIK
  • Practitioner IFU
  • Privacy Policy
  • PROSE Provider Payment Form
  • PROSE Treatment
  • Publications
  • Research
  • Research Studies
  • Sjögren’s Disease
  • Software Platforms
  • Stevens-Johnson Syndrome
  • Technology
  • Terms of Use
  • Visiting Clinicians
  • Ways to Support Us

Categories

  • Blog Posts
  • Clinic Updates
  • In the Media
  • Patient Stories
  • Press Release
  • PROSE
  • SCLERAL

Archive

  • May 2026
  • April 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025
  • May 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • May 2023
  • March 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • March 2020
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing Lab
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Partners
  • Needham PROSE Clinic
  • Donate
  • Contact Us

© 2026 BostonSight. All rights reserved.

Privacy PolicyTerms of Use

Scroll to top Scroll to top Scroll to top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Save & Accept